Gateway's sale of Healthway Medical notes to third parties raises eyebrows
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
AHEAD of Healthway Medical Corporation's (HMC) extraordinary general meeting (EGM) to vote on the second tranche of S$60 million convertible notes, some minority shareholders have raised concerns whether private-equity fund Gateway Partners is there to make a quick buck at their expense.
Questions have risen over why Gateway chose to sell its first tranche of S$10 million in convertible notes to third parties after Lippo-linked Gentle Care has made an offer to buy over these notes at the same price it is offering to pay for each share of HMC.
Copyright SPH Media. All rights reserved.
TRENDING NOW
StarHub hands Ensign InfoSecurity control back to Temasek in S$115 million deal, books S$200 million gain
Singaporeans can now buy record amount of yen per Singdollar
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
Keppel DC Reit posts 13.2% higher Q1 DPU of S$0.02833 on strong portfolio performance